[1] Chang CC, Sorrell TC, Chen SCA. Pulmonary cryptococcosis. Semin Respir Crit Care Med, 2015; 36, 681−91. doi:  10.1055/s-0035-1562895
[2] Wang XC, Mohammad IS, Fan LF, et al. Delivery strategies of amphotericin B for invasive fungal infections. Acta Pharm Sin B, 2021; 11, 2585−604. doi:  10.1016/j.apsb.2021.04.010
[3] Ordaya EE, Abu Saleh OM, Vergidis P, et al. Temporal trends in antifungal susceptibility of Cryptococcus neoformans isolates from a reference laboratory in the United States, 2011-2021. Mycoses, 2024; 67, e13691. doi:  10.1111/myc.13691
[4] Bagga R, Kavanoor Sridhar K. The silent pandemic: antifungal resistance and the future of invasive fungal disease management. Microorganisms, 2026; 14, 599. doi:  10.3390/microorganisms14030599
[5] Bahn YS, Geunes-Boyer S, Heitman J. Ssk2 mitogen-activated protein kinase kinase kinase governs divergent patterns of the stress-activated Hog1 signaling pathway in Cryptococcus neoformans. Eukaryot Cell, 2007; 6, 2278−89. doi:  10.1128/EC.00349-07
[6] Cingolani P, Patel VM, Coon M, et al. Using Drosophila melanogaster as a model for genotoxic chemical mutational studies with a new program, SnpSift. Front Genet, 2012; 3, 35.
[7] Liu OW, Chun CD, Chow ED, et al. Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcus neoformans. Cell, 2008; 135, 174−88. doi:  10.1016/j.cell.2008.07.046
[8] Chen SCA, Meyer W, Sorrell TC. Cryptococcus gattii infections. Clin Microbiol Rev, 2014; 27, 980−1024. doi:  10.1128/CMR.00126-13
[9] Lin JF, Fan YM, Lin XR. Transformation of Cryptococcus neoformans by electroporation using a transient CRISPR-Cas9 expression (TRACE) system. Fungal Genet Biol, 2020; 138, 103364. doi:  10.1016/j.fgb.2020.103364
[10] Lozano-Chiu M, Paetznick VL, Ghannoum MA, et al. Detection of resistance to amphotericin B among Cryptococcus neoformans clinical isolates: performances of three different media assessed by using E-test and National Committee for Clinical Laboratory Standards M27-A methodologies. J Clin Microbiol, 1998; 36, 2817−22. doi:  10.1128/JCM.36.10.2817-2822.1998
[11] Fernandes KE, Dwyer C, Campbell LT, et al. Species in the Cryptococcus gattii complex differ in capsule and cell size following growth under capsule-inducing conditions. mSphere, 2016; 1, e00350−16. doi:  10.1128/msphere.00350-16
[12] Lee D, Jang EH, Lee M, et al. Unraveling melanin biosynthesis and signaling networks in Cryptococcus neoformans. mBio, 2019; 10, e02267−19.
[13] Parkhomchuk D, Borodina T, Amstislavskiy V, et al. Transcriptome analysis by strand-specific sequencing of complementary DNA. Nucleic Acids Res, 2009; 37, e123. doi:  10.1093/nar/gkp596
[14] Espinel-Ingroff A, Chowdhary A, Cuenca-Estrella M, et al. Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine. Antimicrob Agents Chemother, 2012; 56, 3107−13. doi:  10.1128/AAC.06252-11
[15] Córdoba S, Isla MG, Szusz W, et al. Susceptibility profile and epidemiological cut-off values of Cryptococcus neoformans species complex from Argentina. Mycoses, 2016; 59, 351−6. doi:  10.1111/myc.12479
[16] Bicanic T, Harrison T, Niepieklo A, et al. Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution. Clin Infect Dis, 2006; 43, 1069−73. doi:  10.1086/507895
[17] Roth C, Murray D, Scott A, et al. Pleiotropy and epistasis within and between signaling pathways defines the genetic architecture of fungal virulence. PLoS Genet, 2021; 17, e1009313. doi:  10.1371/journal.pgen.1009313
[18] Guirao-Abad JP, Sánchez-Fresneda R, Alburquerque B, et al. ROS formation is a differential contributory factor to the fungicidal action of Amphotericin B and Micafungin in Candida albicans. Int J Med Microbiol, 2017; 307, 241−8. doi:  10.1016/j.ijmm.2017.03.005
[19] Sangalli-Leite F, Scorzoni L, Mesa-Arango AC, et al. Amphotericin B mediates killing in Cryptococcus neoformans through the induction of a strong oxidative burst. Microbes Infect, 2011; 13, 457−67. doi:  10.1016/j.micinf.2011.01.015
[20] Mesa-Arango AC, Scorzoni L, Zaragoza O. It only takes one to do many jobs: amphotericin B as antifungal and immunomodulatory drug. Front Microbiol, 2012; 3, 286.
[21] Liang TY, Chen W, Yang XY, et al. The elevated endogenous reactive oxygen species contribute to the sensitivity of the amphotericin B-resistant isolate of Aspergillus flavus to triazoles and echinocandins. Front Microbiol, 2021; 12, 680749. doi:  10.3389/fmicb.2021.680749
[22] Huang YM, Deng HY, Zang XL, et al. The catalase gene CAT2 and its role in the virulence of one sub-cluster of Cryptococcus gattii VGI clinical isolates. Acta Biochim Biophys Sin, 2026; 58, 1866−74. doi:  10.3724/abbs.2025170
[23] Bahn YS, Kojima K, Cox GM, et al. A unique fungal two-component system regulates stress responses, drug sensitivity, sexual development, and virulence of Cryptococcus neoformans. Mol Biol Cell, 2006; 17, 3122−35. doi:  10.1091/mbc.e06-02-0113
[24] La Santrer E, Assunção CB, de Camargo TMN, et al. The protein kinases family in fungi: adaptability, virulence and conservation between species. Front Microbiol, 2025; 16, 1630196. doi:  10.3389/fmicb.2025.1630196